EW — Edwards Lifesciences
Health Care|Health Care Equipment
2 Articles
EWEarningspositive
Edwards Lifesciences Beats Q1 Estimates, Raises Full-Year Guidance on TAVR Strength
Edwards Lifesciences reported Q1 2026 adjusted EPS of $0.78, beating estimates, with revenue growing 16.7% to $1.65 billion driven by strong TAVR sales.
4 min read
EWEarningsneutral
Edwards Lifesciences Reports Q4 2025 Earnings Results
Edwards Lifesciences (EW) reported fourth quarter 2025 financial results on February 10, 2026.
2 min read